Product Information
ERYTHROMYCIN 400 MG/5 ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.7254 per ML under NDC 62559063101. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559063101
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA062055FDA Approved
Before 1982
TE Code
AB
On Market Since
3/25/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7254 per ML |
|---|---|
| All-time high | $3.0813 (Aug 10, 2022) |
| All-time low | $1.7254 (Aug 19, 2026) |
| 52-week high | $2.2830 |
| 52-week low | $1.7254 |
| Median price | $2.2271 |
| Average price | $2.3225 |
| Largest weekly change | -20.3% (Apr 17, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Erythromycin Ethylsuccinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 400 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 400 MG/5 ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $1.7254 per ML (NDC 62559063101), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN 400 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has declined 44.0%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 400 MG/5 ML SUSP?
Since Mar 23, 2022, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has ranged from a low of $1.7254 (Aug 19, 2026) to a high of $3.0813 (Aug 10, 2022), with a median of $2.2271 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 400 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN 400 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN 400 MG/5 ML SUSP?
ERYTHROMYCIN 400 MG/5 ML SUSP (NDC 62559063101) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.